These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 26418356)
1. The European antibody network's practical guide to finding and validating suitable antibodies for research. Roncador G; Engel P; Maestre L; Anderson AP; Cordell JL; Cragg MS; Šerbec VČ; Jones M; Lisnic VJ; Kremer L; Li D; Koch-Nolte F; Pascual N; Rodríguez-Barbosa JI; Torensma R; Turley H; Pulford K; Banham AH MAbs; 2016; 8(1):27-36. PubMed ID: 26418356 [TBL] [Abstract][Full Text] [Related]
2. A dataset describing a suite of novel antibody reagents for the RAS signaling network. Schoenherr RM; Huang D; Voytovich UJ; Ivey RG; Kennedy JJ; Saul RG; Colantonio S; Roberts RR; Knotts JG; Kaczmarczyk JA; Perry C; Hewitt SM; Bocik W; Whiteley GR; Hiltke T; Boja ES; Rodriguez H; Whiteaker JR; Paulovich AG Sci Data; 2019 Aug; 6(1):160. PubMed ID: 31467290 [TBL] [Abstract][Full Text] [Related]
3. CiteAb: a searchable antibody database that ranks antibodies by the number of times they have been cited. Helsby MA; Leader PM; Fenn JR; Gulsen T; Bryant C; Doughton G; Sharpe B; Whitley P; Caunt CJ; James K; Pope AD; Kelly DH; Chalmers AD BMC Cell Biol; 2014 Feb; 15():6. PubMed ID: 24528853 [TBL] [Abstract][Full Text] [Related]
4. Antibody validation: a view from the mountains. Taussig MJ; Fonseca C; Trimmer JS N Biotechnol; 2018 Oct; 45():1-8. PubMed ID: 30086383 [TBL] [Abstract][Full Text] [Related]
5. Antibody Validation Strategy for Nuclear Receptors. Katona B; Ibrahim A; Sundberg M; Williams C Methods Mol Biol; 2019; 1966():79-99. PubMed ID: 31041740 [TBL] [Abstract][Full Text] [Related]
6. Validating Antibody Specificities for Immunohistochemistry by Protein Blotting Methods. Kurien BT; Scofield RH Methods Mol Biol; 2017; 1554():61-73. PubMed ID: 28185183 [TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of D-dimer specific monoclonal antibodies for use in latex agglutination test. Török-Nagy B; Antal J; Dénes B PLoS One; 2019; 14(2):e0212104. PubMed ID: 30763351 [TBL] [Abstract][Full Text] [Related]
9. A research roadmap for complementary and alternative medicine - what we need to know by 2020. Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850 [TBL] [Abstract][Full Text] [Related]
10. Optimization of the decision-making process for the selection of therapeutics to undergo clinical testing for spinal cord injury in the North American Clinical Trials Network. Guest J; Harrop JS; Aarabi B; Grossman RG; Fawcett JW; Fehlings MG; Tator CH J Neurosurg Spine; 2012 Sep; 17(1 Suppl):94-101. PubMed ID: 22985376 [TBL] [Abstract][Full Text] [Related]
12. A call to adopt a "fit for purpose" approach to antibody validation for flow cytometry analyses of stem cell models and beyond. Waas M; Gundry RL Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H954-H957. PubMed ID: 31559827 [TBL] [Abstract][Full Text] [Related]
13. European collaborative study of luteinizing hormone assay: 1. Epitope specificity of luteinizing hormone monoclonal antibodies and surface mapping of pituitary and urinary luteinizing hormone. Costagliola S; Niccoli P; Florentino M; Carayon P J Endocrinol Invest; 1994 Jun; 17(6):397-406. PubMed ID: 7523479 [TBL] [Abstract][Full Text] [Related]